Prevention of venous thromboembolism after acute ischemic stroke with enoxaparin versus unfractionated heparin and the impact of stroke severity.

被引:0
|
作者
Sherman, David G.
Albers, Gregory W.
Bladin, Christopher
Chen, Min
Fieschi, Cesare
Gabbai, Alberto A.
Kase, Carlos S.
O'Riordan, William
Pineo, Graham F.
机构
[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
[2] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
[3] Monash Univ, Box Hill Hosp, Melbourne, Vic 3004, Australia
[4] Sanofi Aventis, Bridgewater, NJ USA
[5] Univ Roma La Sapienza, Rome, Italy
[6] Univ Fed Sao Paulo, Sao Paulo, Brazil
[7] Boston Univ, Sch Med, Boston, MA 02118 USA
[8] Paradise Valley Hosp, Chula Vista, CA USA
[9] Univ Calgary, Calgary, AB, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
713
引用
收藏
页码:214A / 214A
页数:1
相关论文
共 50 条
  • [21] Venous thromboembolism prevention with low molecular weight heparin may reduce hemorrhagic transformation in acute ischemic stroke
    Muscari, Antonio
    Bartoli, Elena
    Faccioli, Luca
    Franchi, Elena
    Trossello, Marco Pastore
    Puddu, Giovanni M.
    Spinardi, Luca
    Zoli, Marco
    NEUROLOGICAL SCIENCES, 2020, 41 (09) : 2485 - 2494
  • [22] Venous thromboembolism after acute stroke
    Sandercock, P
    Dennis, M
    STROKE, 2001, 32 (06) : 1445 - 1445
  • [23] Venous thromboembolism prevention with low molecular weight heparin may reduce hemorrhagic transformation in acute ischemic stroke
    Antonio Muscari
    Elena Bartoli
    Luca Faccioli
    Elena Franchi
    Marco Pastore Trossello
    Giovanni M. Puddu
    Luca Spinardi
    Marco Zoli
    Neurological Sciences, 2020, 41 : 2485 - 2494
  • [24] The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venousthromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison
    Sherman, David G.
    Albers, Gregory W.
    Bladin, Christopher
    Fieschi, Cesare
    Gabbai, Alberto A.
    Kase, Carlos S.
    O'Riordan, William
    Pineo, Graham F.
    LANCET, 2007, 369 (9570): : 1347 - 1355
  • [26] Economic Impact of Enoxaparin After Acute Ischemic Stroke Based on PREVAIL
    Pineo, Graham
    Lin, Jay
    Stern, Lee
    Subrahmanian, Tarun
    Annemans, Lieven
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2011, 17 (02) : 150 - 157
  • [27] Acute ischemic heart disease - Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease
    Kleber, FX
    Witt, C
    Vogel, G
    Koppenhagen, K
    Schomaker, U
    Flosbach, CW
    AMERICAN HEART JOURNAL, 2003, 145 (04) : 614 - 621
  • [28] PHARMACOECONOMIC MODEL OF ENOXAPARIN VERSUS HEPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM IN MEDICAL PATIENTS
    Milani-Jr, R. R.
    Follador, W.
    Goncalves, J.
    Di Sena, V
    VALUE IN HEALTH, 2009, 12 (03) : A147 - A147
  • [29] EFFICACY AND SAFETY OF ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR PREVENTION OF DEEP VENOUS THROMBOSIS AFTER ELECTIVE KNEE ARTHROPLASTY
    COLWELL, CW
    SPIRO, TE
    TROWBRIDGE, AA
    STEPHENS, JWG
    GARDINER, GA
    RITTER, MA
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1995, (321) : 19 - 27
  • [30] Venous thromboembolism after acute stroke - Response
    Kelly, J
    Rudd, A
    Lewis, R
    Hunt, BJ
    STROKE, 2001, 32 (06) : 1446 - 1446